Cargando…

Portal Venous Circulating Tumor Cells Undergoing Epithelial-Mesenchymal Transition Exhibit Distinct Clinical Significance in Pancreatic Ductal Adenocarcinoma

BACKGROUND: Much importance is attached to the clinical application value of circulating tumor cells (CTCs), meanwhile tumor-proximal CTCs detection has interested researchers for its unique advantage. This research mainly discusses the correlation of portal venous (PoV) CTCs counts in different epi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yujin, Li, Deyu, Yang, Jiuhui, Wang, Ning, Xiao, Erwei, Tao, Lianyuan, Ding, Xiangming, Sun, Peichun, Li, Dongxiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582019/ https://www.ncbi.nlm.nih.gov/pubmed/34778073 http://dx.doi.org/10.3389/fonc.2021.757307

Ejemplares similares

Preoperative Oral Carbohydrate Levels in Patients with Type 2 Diabetes Mellitus: The Clinical Guiding Significance of Free Fatty Acids
por: Yang, Jiuhui, et al.
Publicado: (2022)

Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma
por: Ge, Jiachen, et al.
Publicado: (2022)

Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma
por: Lu, Yuanxiang, et al.
Publicado: (2021)

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
por: Wu, Huanwen, et al.
Publicado: (2022)

Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis
por: Tao, Lianyuan, et al.
Publicado: (2016)

Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation
por: Arnoletti, Juan Pablo, et al.
Publicado: (2022)

Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy
por: Lindgaard, Sidsel C., et al.
Publicado: (2022)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma
por: XUE, ZHANXIONG, et al.
Publicado: (2016)

G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma
por: Zhang, Lingfu, et al.
Publicado: (2018)

Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
por: Gablo, Natalia, et al.
Publicado: (2020)

Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion
por: Oba, A., et al.
Publicado: (2020)

Multi‐omics analysis of intra‐tumoural and inter‐tumoural heterogeneity in pancreatic ductal adenocarcinoma
por: Liu, Xiaoqian, et al.
Publicado: (2022)

Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase
por: Reinert, Christian Philipp, et al.
Publicado: (2020)

Dual-Layer Spectral CT of Pancreas Ductal Adenocarcinoma: Can Virtual Monoenergetic Images of the Portal Venous Phase Be an Alternative to the Pancreatic-Phase Scan?
por: Han, Yeo Eun, et al.
Publicado: (2022)

Postoperative metastasis prediction based on portal vein circulating tumor cells detected by flow cytometry in periampullary or pancreatic cancer
por: Tao, Lianyuan, et al.
Publicado: (2019)

Correction to: Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal‑venous enhancement phase
por: Reinert, Christian Philipp, et al.
Publicado: (2021)

Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC)
por: Tao, Lianyuan, et al.
Publicado: (2016)

Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma
por: McGowan, Ryan, et al.
Publicado: (2022)

Effect of Fluid Shear Stress on Portal Vein Remodeling in a Rat Model of Portal Hypertension
por: Wen, Bin, et al.
Publicado: (2015)

What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?
por: Navez, Julie, et al.
Publicado: (2021)

Portal vein resection and reconstruction with artificial blood vessels is safe and feasible for pancreatic ductal adenocarcinoma patients with portal vein involvement: Chinese center experience
por: Xie, Zhi-Bo, et al.
Publicado: (2017)

Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer
por: Choi, Young Hoon, et al.
Publicado: (2022)

Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer
por: Ko, Sung Woo, et al.
Publicado: (2023)

Pneumatosis intestinalis and portal venous gas secondary to Gefitinib therapy for lung adenocarcinoma
por: Lee, Joo Young, et al.
Publicado: (2012)

Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model
por: Mallya, Kavita, et al.
Publicado: (2020)

A model for the detection of pancreatic ductal adenocarcinoma circulating tumor cells
por: Alexander, Matthew S., et al.
Publicado: (2018)

Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Dopico, Pablo J., et al.
Publicado: (2022)

Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients
por: Mayado, Andrea, et al.
Publicado: (2020)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

Analysis of distinct long noncoding RNA transcriptional fingerprints in pancreatic ductal adenocarcinoma
por: Yu, Xiang, et al.
Publicado: (2017)

Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma
por: Reni, Michele, et al.
Publicado: (2020)

Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
por: Hansen, Frederik J., et al.
Publicado: (2023)

Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma
por: Topham, James T., et al.
Publicado: (2023)

Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
por: Lee, Jee‐Soo, et al.
Publicado: (2019)

Circulating Innate Lymphoid Cells Exhibit Distinctive Distribution During Normal Pregnancy
por: Zhao, Yiran, et al.
Publicado: (2022)

Radiomics-Assisted Presurgical Prediction for Surgical Portal Vein-Superior Mesenteric Vein Invasion in Pancreatic Ductal Adenocarcinoma
por: Chen, Fangming, et al.
Publicado: (2020)

Hepatic portal venous gas
por: Soon, Wai Cheong, et al.
Publicado: (2015)

Response to letter to the editor regarding the article “Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase”
por: Reinert, Christian Philipp, et al.
Publicado: (2020)

Pancreatoduodenectomy with portal vein resection favors the survival time of patients with pancreatic ductal adenocarcinoma: A propensity score matching analysis
por: Xie, Zhi-Bo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9unk8e5f926n4b8r6qpokhqa90